Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Gordon

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Data in Brief|August 30, 2016
Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytesSylwia Wasiak, Dean Gilham, Laura M Tsujikawa, et al.
Journal of the American College of Cardiology|June 2, 2010
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivoDana Bailey, Ravi Jahagirdar, Allan Gordon, et al.
Pain Research & Management|July 8, 2014
iCanCope with Pain™: User-centred design of a web- and mobile-based self-management program for youth with chronic pain based on identified health care needsJennifer N Stinson, Chitra Lalloo, Lauren Harris, et al.
Pain|February 2, 2017
The reciprocal associations between catastrophizing and pain outcomes in patients being treated for neuropathic pain: a cross-lagged panel analysis studyMélanie Racine, Dwight E Moulin, Warren R Nielson, et al.
Pain Medicine (Malden, Mass.)|February 4, 2015
Physical Functioning and Opioid use in Patients with Neuropathic PainGeoff P Bostick, Cory Toth, Eloise C J Carr, et al.
Pharmaceutical Statistics|March 15, 2019
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873Thomas Jaki, Allan Gordon, Pamela Forster, et al.
Pain|September 9, 2008
An interfaculty pain curriculum: lessons learned from six years experienceJudith Hunter, Judy Watt-Watson, Michael McGillion, et al.
BMJ Open|November 28, 2017
Self-management of cardiac pain in women: an evidence mapMonica Parry, Ann Kristin Bjørnnes, Hance Clarke, et al.
Clinical Therapeutics|August 6, 2010
Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phaseAllan Gordon, Denis Callaghan, Donald Spink, et al.
Pain Research & Management|December 6, 2014
Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain SocietyDwight Moulin, Aline Boulanger, A J Clark, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Data in Brief|August 30, 2016
Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytesSylwia Wasiak, Dean Gilham, Laura M Tsujikawa, et al.
Journal of the American College of Cardiology|June 2, 2010
RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivoDana Bailey, Ravi Jahagirdar, Allan Gordon, et al.
Pain Research & Management|July 8, 2014
iCanCope with Pain™: User-centred design of a web- and mobile-based self-management program for youth with chronic pain based on identified health care needsJennifer N Stinson, Chitra Lalloo, Lauren Harris, et al.
Pain|February 2, 2017
The reciprocal associations between catastrophizing and pain outcomes in patients being treated for neuropathic pain: a cross-lagged panel analysis studyMélanie Racine, Dwight E Moulin, Warren R Nielson, et al.
Pain Medicine (Malden, Mass.)|February 4, 2015
Physical Functioning and Opioid use in Patients with Neuropathic PainGeoff P Bostick, Cory Toth, Eloise C J Carr, et al.
Pharmaceutical Statistics|March 15, 2019
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593-606, Sep/Oct 2018., DOI: https://doi.org/10.1002/pst.1873Thomas Jaki, Allan Gordon, Pamela Forster, et al.
Pain|September 9, 2008
An interfaculty pain curriculum: lessons learned from six years experienceJudith Hunter, Judy Watt-Watson, Michael McGillion, et al.
BMJ Open|November 28, 2017
Self-management of cardiac pain in women: an evidence mapMonica Parry, Ann Kristin Bjørnnes, Hance Clarke, et al.
Clinical Therapeutics|August 6, 2010
Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phaseAllan Gordon, Denis Callaghan, Donald Spink, et al.
Pain Research & Management|December 6, 2014
Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain SocietyDwight Moulin, Aline Boulanger, A J Clark, et al.
Pageof 6